LLY

1,167.15

+2.65%↑

JNJ

240.75

+0.91%↑

ABBV

227.25

+0.38%↑

UNH

406.9

+0.41%↑

MRK

122.26

+3.04%↑

LLY

1,167.15

+2.65%↑

JNJ

240.75

+0.91%↑

ABBV

227.25

+0.38%↑

UNH

406.9

+0.41%↑

MRK

122.26

+3.04%↑

LLY

1,167.15

+2.65%↑

JNJ

240.75

+0.91%↑

ABBV

227.25

+0.38%↑

UNH

406.9

+0.41%↑

MRK

122.26

+3.04%↑

LLY

1,167.15

+2.65%↑

JNJ

240.75

+0.91%↑

ABBV

227.25

+0.38%↑

UNH

406.9

+0.41%↑

MRK

122.26

+3.04%↑

LLY

1,167.15

+2.65%↑

JNJ

240.75

+0.91%↑

ABBV

227.25

+0.38%↑

UNH

406.9

+0.41%↑

MRK

122.26

+3.04%↑

Search

Illumina Inc

Открыт

СекторЗдравоохранение

164.93 1.45

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

160.26

Макс.

165.14

Ключевые показатели

By Trading Economics

Доход

-200M

134M

Продажи

-68M

1.1B

P/E

Средняя по отрасли

28.735

49.052

Прибыль на акцию

1.15

Рентабельность продаж

12.282

Сотрудники

8,600

EBITDA

-144M

301M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

-9.37% downside

Дивиденды

By Acuity

Следующий отчет о доходах

30 июл. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

4.4B

24B

Предыдущая цена открытия

163.48

Предыдущая цена закрытия

164.93

Новостные настроения

By Acuity

52%

48%

262 / 344 Рейтинг в Healthcare

Illumina Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

10 июн. 2026 г., 23:11 UTC

Illumina Inc shares are higher in after-market trading, supported by a notable upward trend in the Life Sciences Tools & Services sub-sector.

9 июн. 2026 г., 19:26 UTC

News

Illumina shares are advancing, supported by a consensus "Hold" rating from analysts and an average price target of $138.38.

8 июн. 2026 г., 20:06 UTC

News

Illumina Inc launched the StrataMap Spatial Solution, yet shares are declining amid broader market sentiment and sector challenges.

5 июн. 2026 г., 23:16 UTC

Correlated Moves

Illumina Inc shares are roughly flat in after-market trading, reflecting broader market dynamics amid a slight decline in the Russell 2000 Index.

4 июн. 2026 г., 19:51 UTC

Illumina Inc shares are lower today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this decline.

3 июн. 2026 г., 23:03 UTC

Illumina Inc shares are higher in after-market trading, maintaining levels above its 20-day moving average amid broader market concerns about inflation and geopolitical tensions.

2 июн. 2026 г., 23:21 UTC

Correlated Moves

Illumina Inc shares declined in after-market trading, reflecting broader market trends amid mixed economic signals and a stronger-than-expected JOLTS job openings report.

1 июн. 2026 г., 23:46 UTC

Illumina Inc shares are higher in after-market trading following a report showing U.S. manufacturing activity expanded for the fifth consecutive month.

29 мая 2026 г., 20:03 UTC

Illumina Inc is higher in Friday's session, maintaining gains since Thursday's close. No specific news was identified to explain the price action.

28 мая 2026 г., 23:26 UTC

Illumina Inc shares are higher in after-market hours, reflecting routine trading activity. No specific news has been identified to explain the movement.

27 мая 2026 г., 20:02 UTC

Illumina Inc is trading higher, maintaining strong momentum and peaking during Wednesday's session, despite no specific company news identified for the movement.

21 мая 2026 г., 19:42 UTC

Illumina Inc's shares are higher during Thursday's session, recovering from an earlier dip and trading near the upper end of their one-month range.

20 мая 2026 г., 19:56 UTC

News

Illumina Inc's stock is lower after Yahoo Finance's analysis cites weak revenue growth and concerns over its business quality. Shares rebounded earlier in the session.

19 мая 2026 г., 20:03 UTC

Illumina Inc's shares are higher, supported by gains in the Life Sciences Tools & Services sub-sector, despite midday fluctuations.

18 мая 2026 г., 19:15 UTC

Correlated Moves

Illumina Inc shares are lower, continuing a four-session decline amid rising Treasury yields and broader market trends, including a drop in the Russell 2000 Index.

15 мая 2026 г., 23:56 UTC

Illumina Inc shares are lower in after-market hours, following a decline during the session amid broader market volatility and rising initial jobless claims.

14 мая 2026 г., 23:26 UTC

News

RBC Capital initiated coverage on Illumina Inc with an Outperform rating and a $170 price target. Shares are higher in after-market trading.

13 мая 2026 г., 23:21 UTC

Illumina Inc's shares are higher in after-market trading, maintaining strength above its 20-day moving average and near the top of its one-month range.

12 мая 2026 г., 23:16 UTC

Correlated Moves

Illumina Inc shares are lower in after-market trading, reflecting broader market sentiment amid rising U.S. consumer prices and inflation concerns.

11 мая 2026 г., 23:31 UTC

Illumina Inc shows notable after-hours gains following a recent dip. The stock remains significantly above its 20-day moving average, reflecting strong performance.

8 мая 2026 г., 23:02 UTC

Correlated Moves

Illumina Inc shares fell in after-hours trading, reflecting market concerns. Despite tech strength, including Nasdaq gains, Illumina's performance lagged behind.

7 мая 2026 г., 23:01 UTC

Correlated Moves

Illumina Inc declines in after-hours trading, reversing earlier gains. This drop coincides with a slight dip in high-yield corporate bonds, reflecting broader market sentiment.

6 мая 2026 г., 19:06 UTC

Correlated Moves

Illumina Inc is trading higher today amid positive market sentiment. The rise in convertible and high-yield bond ETFs suggests a supportive environment for equities.

5 мая 2026 г., 19:56 UTC

Correlated Moves

Illumina Inc is trading lower today, influenced by declines in the ARK Genomic Revolution ETF. Despite this, the stock remains above its 20-day moving average.

4 мая 2026 г., 19:36 UTC

News

Illumina Inc reports strong Q1 2026 results, with revenue at $1.09 billion, exceeding expectations. Shares are trading higher, reflecting positive market sentiment.

1 мая 2026 г., 20:02 UTC

News
Social Media

Illumina Inc reports strong Q1 results, beating EPS and revenue estimates. The company raises fiscal year 2026 guidance and announces a $1.5 billion stock buyback.

30 апр. 2026 г., 14:02 UTC

Correlated Moves

Illumina Inc is trading higher, reflecting a notable uptick. This rise coincides with a 1.23% increase in the Dow Jones Index, suggesting market influence.

29 апр. 2026 г., 18:12 UTC

Correlated Moves

Illumina Inc is trading significantly lower today, reflecting broader market sentiment. This decline positions it below its 20-day moving average, indicating challenging performance.

Сравнение c конкурентами

Изменение цены

Illumina Inc Прогноз

Целевая цена

By TipRanks

-9.37% падение

Прогноз на 12 месяцев

Средняя 147.25 USD  -9.37%

Максимум 185 USD

Минимум 95 USD

Основано на мнении 12 аналитиков Wall Street, спрогнозировавших целевые цены для Illumina Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

12 ratings

7

Покупка

2

Удержание

3

Продажа

Настроения

By Acuity

262 / 344Рейтинг в Здравоохранение

Новостные настроения

Свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat